HCPCS J1448: Injection, trilaciclib, 1mg
HCPCS Level II code J1448 describes a 1 mg injectable dose of trilaciclib, used as an intravenous pharmacologic agent to protect bone marrow during cytotoxic chemotherapy; service type: injection/infusion medication administration; typical site of service: hospital outpatient infusion center or oncology clinic.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J1448 policy alerts
Get alerted when payer policies referencing J1448 are released or updated.
Monitor payer policy activity